Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-Center, Randomized Trial Comparing the IBS Titan™ Sirolimus-Eluting Iron Bioresorbable Peripheral Scaffold System vs. Standard Balloon Angioplasty for Treatment of Below-the-Knee Arteries: GENIUS TRIAL

NCT04849325 is registered in ClinicalTrials.gov with Biotyx Medical (Shenzhen) Co., Ltd. as lead sponsor.

NCT NCT04849325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04849325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-Center, Randomized Trial Comparing the IBS Titan™ Sirolimus-Eluting Iron Bioresorbable Peripheral Scaffold System vs. Standard Balloon Angioplasty for Treatment of Below-the-Knee Arteries: GENIUS TRIAL
Lead sponsor
Biotyx Medical (Shenzhen) Co., Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
December 9, 2021
Completion date
October 31, 2024
Enrollment
120 (estimated)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia (cli)